{
  "legislationId": "119_HR_7777",
  "lastUpdate": "2026-04-17T11:39:13.532Z",
  "history": [
    {
      "timestamp": "2026-04-17T11:39:13.532Z",
      "source_url": "https://www.congress.gov/119/bills/hr7777/BILLS-119hr7777ih.htm",
      "model": "gemini-3.1-pro-preview",
      "prompt_sent": "\nJesteś LEGISLATIVE SURGEON.\nTwoim zadaniem jest audyt i naprawa streszczenia (JSON) pod kątem zgodności z tekstem źródłowym (SOURCE).\nZASADA FUNDAMENTALNA: \"NO NEW INFORMATION\" (żadnych nowych informacji).\nStreszczenie może jedynie transformować informacje zawarte w SOURCE (skracać, tłumaczyć, sumować). Nie może generować nowych informacji, których nie ma w SOURCE.\n\nPROCEDURA WERYFIKACJI (wykonaj dla każdego zdania w JSON):\nZadaj sobie pytanie: \"Czy potrafię wskazać w SOURCE konkretny fragment, który potwierdza to stwierdzenie?\"\nJEŚLI ODPOWIEDŹ BRZMI \"TAK\":\nInformacja jest potwierdzona cytatem, synonimem lub wynikiem matematycznym z danych w tekście.\nDECYZJA: Zostaw bez zmian.\nJEŚLI ODPOWIEDŹ BRZMI \"NIE\":\nInformacji nie ma w tekście (jest to halucynacja, zewnętrzna wiedza modelu, nadinterpretacja lub niepotrzebna ekstrapolacja).\nDECYZJA: Usuń tę informację lub zmień ją tak, aby miała pokrycie w tekście.\nJEŚLI ODPOWIEDŹ BRZMI \"TO ZALEŻY\":\nTekst jest niejasny, a streszczenie \"zgaduje\" (np. podając konkretny przykład dla ogólnego terminu).\nDECYZJA: Bądź bezpieczny. Usuń zgadywanie. Użyj terminologii z tekstu.\n\nKATEGORIE RYZYKA (szczególna uwaga):\nDaty (start obowiązywania vs start finansowania).\nLiczby (konkretne kwoty muszą wynikać z tekstu).\nPodmioty (kto co robi).\nZakres (co ustawa obejmuje, a czego nie).\n\nINPUT:\n--- SOURCE_TEXT START ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7777 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7777 To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services _______________________________________________________________________ A BILL To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting America's Medical Supply Chains Act of 2026''. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) Statement of Policy.--Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended-- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: ``(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;''. (b) Strengthening Domestic Capability.--Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended-- (1) in subsection (a), by inserting ``(including medical materials)'' after ``materials''; and (2) in subsection (b)(1), by inserting ``(including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense)'' after ``essential materials''. (c) Strategy on Securing Supply Chains for Medical Materials.-- Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following: ``SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS. ``(a) In General.--Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following: ``(1) A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act. ``(2) An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities. ``(3) Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense. ``(4) A discussion of-- ``(A) any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs; ``(B) a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and ``(C) efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies. ``(b) Progress Report.--Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex. ``(c) Appropriate Members of Congress.--In this section, the term `appropriate Members of Congress' means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.''. SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY. (a) In General.--Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following: ``(h) Investment in Supply Chain Security.-- ``(1) In general.--In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States. ``(2) Eligible entity.--An eligible entity described in this paragraph is an entity that-- ``(A) is organized under the laws of the United States or any jurisdiction within the United States; and ``(B) produces-- ``(i) one or more critical components; ``(ii) critical technology; or ``(iii) one or more products or raw materials for the security of supply chains or supply chain activities. ``(3) Definitions.--In this subsection, the terms `supply chain' and `supply chain activities' have the meanings given those terms by the President by regulation.''. (b) Regulations.-- (1) In general.--Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms ``supply chain'' and ``supply chain activities'' for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a). (2) Scope of definitions.--The definitions required by paragraph (1)-- (A) shall encompass-- (i) the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or (ii) critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and (B) may include variations as determined necessary and appropriate by the President for purposes of national defense. <all>\n--- SOURCE_TEXT END ---\n\n--- FLAGGED_JSON START ---\n{\n  \"pl_ai_title\": \"Ustawa o zabezpieczeniu dostaw leków i sprzętu medycznego w USA\",\n  \"pl_summary\": \"Ustawa ma na celu zapewnienie stałego dostępu do niezbędnych leków i wyrobów medycznych poprzez wzmocnienie krajowej produkcji. Dzięki temu obywatele mają mieć pewność, że kluczowe środki medyczne nie zabraknie w sytuacjach kryzysowych.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie strategii ochrony łańcuchów dostaw leków i sprzętu medycznego.\",\n    \"Wsparcie finansowe dla amerykańskich firm produkujących kluczowe komponenty medyczne.\",\n    \"Zmniejszenie zależności od zagranicznych dostawców w obszarze ochrony zdrowia.\",\n    \"Regularne raporty dla Kongresu o stanie bezpieczeństwa medycznego kraju.\"\n  ],\n  \"eng_ai_title\": \"Protecting America's Medical Supply Chains Act of 2026\",\n  \"eng_summary\": \"This act aims to ensure a steady supply of essential medicines and medical devices by strengthening domestic production. It helps guarantee that citizens have access to life-saving treatments even during global supply disruptions.\",\n  \"eng_key_points\": [\n    \"Creates a national strategy to secure medicines and medical equipment.\",\n    \"Provides funding for US companies to improve supply chain security.\",\n    \"Reduces reliance on foreign governments for critical medical components.\",\n    \"Requires annual updates on the availability of essential medical supplies.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Sicherung der medizinischen Lieferketten in den USA\",\n  \"de_summary\": \"Dieses Gesetz soll die Versorgung mit wichtigen Medikamenten und Medizinprodukten durch die Stärkung der heimischen Produktion sicherstellen. Bürger sollen so auch in Krisenzeiten zuverlässigen Zugang zu notwendigen medizinischen Mitteln haben.\",\n  \"de_key_points\": [\n    \"Entwicklung einer Strategie zur Sicherung von Medikamenten- und Gerätelieferungen.\",\n    \"Finanzielle Unterstützung für US-Unternehmen bei der Sicherung von Lieferketten.\",\n    \"Verringerung der Abhängigkeit von ausländischen Lieferanten im Gesundheitsbereich.\",\n    \"Jährliche Berichte über den Stand der medizinischen Versorgungssicherheit.\"\n  ],\n  \"fr_ai_title\": \"Loi sur la protection des chaînes d'approvisionnement médical aux États-Unis\",\n  \"fr_summary\": \"Cette loi vise à garantir un approvisionnement stable en médicaments et dispositifs médicaux essentiels en renforçant la production nationale. Elle assure aux citoyens l'accès aux soins nécessaires, même en cas de crise internationale.\",\n  \"fr_key_points\": [\n    \"Création d'une stratégie nationale pour sécuriser les médicaments et le matériel médical.\",\n    \"Soutien financier aux entreprises américaines pour renforcer leurs chaînes de production.\",\n    \"Réduction de la dépendance envers les gouvernements étrangers pour les composants médicaux critiques.\",\n    \"Rapports annuels sur l'état de la sécurité des approvisionnements médicaux.\"\n  ],\n  \"es_ai_title\": \"Ley de Protección de las Cadenas de Suministro Médico de 2026\",\n  \"es_summary\": \"Esta ley busca asegurar el suministro constante de medicamentos y equipos médicos esenciales mediante el fortalecimiento de la producción nacional. Su objetivo es que los ciudadanos no sufran escasez de tratamientos vitales en momentos de crisis.\",\n  \"es_key_points\": [\n    \"Creación de una estrategia para proteger el suministro de medicinas y equipos.\",\n    \"Apoyo financiero a empresas estadounidenses para asegurar la producción.\",\n    \"Reducción de la dependencia de proveedores extranjeros en el sector salud.\",\n    \"Informes anuales sobre la seguridad y disponibilidad de suministros médicos.\"\n  ],\n  \"it_ai_title\": \"Legge per la protezione delle catene di approvvigionamento medico\",\n  \"it_summary\": \"Questa legge mira a garantire una fornitura costante di farmaci e dispositivi medici essenziali potenziando la produzione interna. L'obiettivo è assicurare ai cittadini l'accesso alle cure necessarie anche durante crisi globali.\",\n  \"it_key_points\": [\n    \"Definizione di una strategia per mettere in sicurezza farmaci e attrezzature mediche.\",\n    \"Sostegno economico alle imprese americane per rafforzare le catene produttive.\",\n    \"Riduzione della dipendenza da governi stranieri per componenti medici critici.\",\n    \"Relazioni annuali sullo stato della sicurezza degli approvvigionamenti sanitari.\"\n  ],\n  \"nl_ai_title\": \"Wet ter bescherming van de medische toeleveringsketens in de VS\",\n  \"nl_summary\": \"Deze wet is bedoeld om de levering van essentiële medicijnen en medische hulpmiddelen te waarborgen door de binnenlandse productie te versterken. Hierdoor krijgen burgers meer zekerheid over de beschikbaarheid van zorgmiddelen in crisistijd.\",\n  \"nl_key_points\": [\n    \"Ontwikkeling van een strategie om de aanvoer van medicijnen en apparatuur te beveiligen.\",\n    \"Financiële steun voor Amerikaanse bedrijven om toeleveringsketens te versterken.\",\n    \"Vermindering van de afhankelijkheid van buitenlandse overheden voor medische producten.\",\n    \"Jaarlijkse rapportages over de status van de medische bevoorradingszekerheid.\"\n  ],\n  \"pt_ai_title\": \"Lei de Proteção das Cadeias de Abastecimento Médico de 2026\",\n  \"pt_summary\": \"Esta lei visa garantir o fornecimento constante de medicamentos e dispositivos médicos essenciais através do reforço da produção nacional. O objetivo é assegurar que os cidadãos tenham acesso a tratamentos vitais mesmo em situações de crise.\",\n  \"pt_key_points\": [\n    \"Criação de uma estratégia para proteger o abastecimento de medicamentos e equipamentos.\",\n    \"Apoio financeiro a empresas americanas para reforçar a segurança da produção.\",\n    \"Redução da dependência de governos estrangeiros para componentes médicos críticos.\",\n    \"Relatórios anuais sobre o estado da segurança dos suprimentos médicos.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Security\",\n    \"Economy\"\n  ]\n}\n--- FLAGGED_JSON END ---\n\nOUTPUT:\nWyłącznie naprawiony obiekt JSON zgodny ze strukturą:\n{\n  \"pl_ai_title\": \"...\", \"pl_summary\": \"...\", \"pl_key_points\": [...],\n  \"eng_ai_title\": \"...\", \"eng_summary\": \"...\", \"eng_key_points\": [...],\n  \"de_ai_title\": \"...\", \"de_summary\": \"...\", \"de_key_points\": [...],\n  \"fr_ai_title\": \"...\", \"fr_summary\": \"...\", \"fr_key_points\": [...],\n  \"es_ai_title\": \"...\", \"es_summary\": \"...\", \"es_key_points\": [...],\n  \"it_ai_title\": \"...\", \"it_summary\": \"...\", \"it_key_points\": [...],\n  \"nl_ai_title\": \"...\", \"nl_summary\": \"...\", \"nl_key_points\": [...],\n  \"pt_ai_title\": \"...\", \"pt_summary\": \"...\", \"pt_key_points\": [...],\n  \"category\": [\"...\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o ochronie amerykańskich medycznych łańcuchów dostaw z 2026 r.\",\n  \"pl_summary\": \"Ustawa ma na celu zapewnienie dostaw niezbędnych materiałów medycznych, w tym leków i wyrobów medycznych, kluczowych dla obrony narodowej, poprzez wzmocnienie krajowych zdolności produkcyjnych i zabezpieczenie łańcuchów dostaw.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie strategii ochrony łańcuchów dostaw materiałów medycznych.\",\n    \"Wsparcie finansowe dla amerykańskich podmiotów w celu zwiększenia bezpieczeństwa łańcuchów dostaw.\",\n    \"Zapobieganie wyłącznej kontroli obcych rządów nad kluczowymi komponentami medycznymi.\",\n    \"Coroczne raporty z postępów dla Kongresu do 2029 roku.\"\n  ],\n  \"eng_ai_title\": \"Protecting America's Medical Supply Chains Act of 2026\",\n  \"eng_summary\": \"This act aims to ensure the supply of essential medical materials, including drugs and devices, critical to national defense by strengthening domestic production capabilities and securing supply chains.\",\n  \"eng_key_points\": [\n    \"Creates a strategy to secure supply chains for medical materials.\",\n    \"Provides payments to US entities to increase supply chain security.\",\n    \"Ensures essential medical components are not under the exclusive control of a foreign government.\",\n    \"Requires annual progress reports to Congress until 2029.\"\n  ],\n  \"de_ai_title\": \"Gesetz zum Schutz der amerikanischen medizinischen Lieferketten von 2026\",\n  \"de_summary\": \"Dieses Gesetz zielt darauf ab, die Versorgung mit für die nationale Verteidigung wesentlichen medizinischen Materialien, einschließlich Medikamenten und Geräten, durch die Stärkung der heimischen Produktionskapazitäten und die Sicherung der Lieferketten zu gewährleisten.\",\n  \"de_key_points\": [\n    \"Entwicklung einer Strategie zur Sicherung der Lieferketten für medizinische Materialien.\",\n    \"Finanzielle Zahlungen an US-Unternehmen zur Erhöhung der Lieferkettensicherheit.\",\n    \"Verhinderung der ausschließlichen Kontrolle ausländischer Regierungen über wesentliche medizinische Komponenten.\",\n    \"Jährliche Fortschrittsberichte an den Kongress bis 2029.\"\n  ],\n  \"fr_ai_title\": \"Loi de 2026 sur la protection des chaînes d'approvisionnement médical en Amérique\",\n  \"fr_summary\": \"Cette loi vise à garantir l'approvisionnement en matériels médicaux essentiels, y compris les médicaments et les dispositifs, cruciaux pour la défense nationale, en renforçant les capacités de production nationales et en sécurisant les chaînes d'approvisionnement.\",\n  \"fr_key_points\": [\n    \"Création d'une stratégie pour sécuriser les chaînes d'approvisionnement en matériels médicaux.\",\n    \"Paiements aux entités américaines pour accroître la sécurité des chaînes d'approvisionnement.\",\n    \"Prévention du contrôle exclusif par un gouvernement étranger des composants médicaux essentiels.\",\n    \"Rapports d'étape annuels au Congrès jusqu'en 2029.\"\n  ],\n  \"es_ai_title\": \"Ley de Protección de las Cadenas de Suministro Médico de Estados Unidos de 2026\",\n  \"es_summary\": \"Esta ley tiene como objetivo garantizar el suministro de materiales médicos esenciales, incluidos medicamentos y dispositivos, críticos para la defensa nacional, mediante el fortalecimiento de las capacidades de producción nacionales y la seguridad de las cadenas de suministro.\",\n  \"es_key_points\": [\n    \"Creación de una estrategia para asegurar las cadenas de suministro de materiales médicos.\",\n    \"Pagos a entidades estadounidenses para aumentar la seguridad de la cadena de suministro.\",\n    \"Prevención del control exclusivo de componentes médicos esenciales por parte de un gobierno extranjero.\",\n    \"Informes anuales de progreso al Congreso hasta 2029.\"\n  ],\n  \"it_ai_title\": \"Legge del 2026 sulla protezione delle catene di approvvigionamento medico in America\",\n  \"it_summary\": \"Questa legge mira a garantire la fornitura di materiali medici essenziali, inclusi farmaci e dispositivi, critici per la difesa nazionale, rafforzando le capacità di produzione interne e mettendo in sicurezza le catene di approvvigionamento.\",\n  \"it_key_points\": [\n    \"Creazione di una strategia per mettere in sicurezza le catene di approvvigionamento di materiali medici.\",\n    \"Pagamenti a entità statunitensi per aumentare la sicurezza della catena di approvvigionamento.\",\n    \"Prevenzione del controllo esclusivo da parte di un governo straniero sui componenti medici essenziali.\",\n    \"Relazioni annuali sui progressi al Congresso fino al 2029.\"\n  ],\n  \"nl_ai_title\": \"Wet ter bescherming van de Amerikaanse medische toeleveringsketens van 2026\",\n  \"nl_summary\": \"Deze wet is bedoeld om de levering van essentiële medische materialen, waaronder medicijnen en hulpmiddelen, die cruciaal zijn voor de nationale defensie, te waarborgen door de binnenlandse productiecapaciteit te versterken en toeleveringsketens te beveiligen.\",\n  \"nl_key_points\": [\n    \"Ontwikkeling van een strategie om toeleveringsketens voor medische materialen te beveiligen.\",\n    \"Betalingen aan Amerikaanse entiteiten om de veiligheid van de toeleveringsketen te vergroten.\",\n    \"Voorkomen dat essentiële medische componenten onder exclusieve controle van een buitenlandse overheid vallen.\",\n    \"Jaarlijkse voortgangsrapportages aan het Congres tot 2029.\"\n  ],\n  \"pt_ai_title\": \"Lei de Proteção das Cadeias de Abastecimento Médico da América de 2026\",\n  \"pt_summary\": \"Esta lei visa garantir o fornecimento de materiais médicos essenciais, incluindo medicamentos e dispositivos, críticos para a defesa nacional, fortalecendo as capacidades de produção nacionais e garantindo a segurança das cadeias de abastecimento.\",\n  \"pt_key_points\": [\n    \"Criação de uma estratégia para proteger as cadeias de abastecimento de materiais médicos.\",\n    \"Pagamentos a entidades dos EUA para aumentar a segurança da cadeia de abastecimento.\",\n    \"Prevenção do controlo exclusivo de componentes médicos essenciais por um governo estrangeiro.\",\n    \"Relatórios anuais de progresso ao Congresso até 2029.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Security\",\n    \"Economy\"\n  ]\n}"
    },
    {
      "timestamp": "2026-04-17T11:35:59.690Z",
      "source_url": "https://www.congress.gov/119/bills/hr7777/BILLS-119hr7777ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7777 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7777 To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services _______________________________________________________________________ A BILL To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting America's Medical Supply Chains Act of 2026''. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) Statement of Policy.--Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended-- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: ``(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;''. (b) Strengthening Domestic Capability.--Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended-- (1) in subsection (a), by inserting ``(including medical materials)'' after ``materials''; and (2) in subsection (b)(1), by inserting ``(including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense)'' after ``essential materials''. (c) Strategy on Securing Supply Chains for Medical Materials.-- Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following: ``SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS. ``(a) In General.--Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following: ``(1) A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act. ``(2) An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities. ``(3) Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense. ``(4) A discussion of-- ``(A) any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs; ``(B) a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and ``(C) efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies. ``(b) Progress Report.--Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex. ``(c) Appropriate Members of Congress.--In this section, the term `appropriate Members of Congress' means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.''. SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY. (a) In General.--Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following: ``(h) Investment in Supply Chain Security.-- ``(1) In general.--In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States. ``(2) Eligible entity.--An eligible entity described in this paragraph is an entity that-- ``(A) is organized under the laws of the United States or any jurisdiction within the United States; and ``(B) produces-- ``(i) one or more critical components; ``(ii) critical technology; or ``(iii) one or more products or raw materials for the security of supply chains or supply chain activities. ``(3) Definitions.--In this subsection, the terms `supply chain' and `supply chain activities' have the meanings given those terms by the President by regulation.''. (b) Regulations.-- (1) In general.--Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms ``supply chain'' and ``supply chain activities'' for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a). (2) Scope of definitions.--The definitions required by paragraph (1)-- (A) shall encompass-- (i) the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or (ii) critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and (B) may include variations as determined necessary and appropriate by the President for purposes of national defense. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Protecting America's Medical Supply Chains Act of 2026\nSummary: This act aims to ensure a steady supply of essential medicines and medical devices by strengthening domestic production. It helps guarantee that citizens have access to life-saving treatments even during global supply disruptions.\nKey Points: Creates a national strategy to secure medicines and medical equipment., Provides funding for US companies to improve supply chain security., Reduces reliance on foreign governments for critical medical components., Requires annual updates on the availability of essential medical supplies.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-04-17T11:33:07.590Z",
      "source_url": "https://www.congress.gov/119/bills/hr7777/BILLS-119hr7777ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7777 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7777 To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services _______________________________________________________________________ A BILL To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting America's Medical Supply Chains Act of 2026''. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) Statement of Policy.--Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended-- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: ``(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;''. (b) Strengthening Domestic Capability.--Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended-- (1) in subsection (a), by inserting ``(including medical materials)'' after ``materials''; and (2) in subsection (b)(1), by inserting ``(including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense)'' after ``essential materials''. (c) Strategy on Securing Supply Chains for Medical Materials.-- Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following: ``SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS. ``(a) In General.--Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following: ``(1) A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act. ``(2) An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities. ``(3) Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense. ``(4) A discussion of-- ``(A) any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs; ``(B) a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and ``(C) efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies. ``(b) Progress Report.--Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex. ``(c) Appropriate Members of Congress.--In this section, the term `appropriate Members of Congress' means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.''. SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY. (a) In General.--Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following: ``(h) Investment in Supply Chain Security.-- ``(1) In general.--In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States. ``(2) Eligible entity.--An eligible entity described in this paragraph is an entity that-- ``(A) is organized under the laws of the United States or any jurisdiction within the United States; and ``(B) produces-- ``(i) one or more critical components; ``(ii) critical technology; or ``(iii) one or more products or raw materials for the security of supply chains or supply chain activities. ``(3) Definitions.--In this subsection, the terms `supply chain' and `supply chain activities' have the meanings given those terms by the President by regulation.''. (b) Regulations.-- (1) In general.--Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms ``supply chain'' and ``supply chain activities'' for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a). (2) Scope of definitions.--The definitions required by paragraph (1)-- (A) shall encompass-- (i) the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or (ii) critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and (B) may include variations as determined necessary and appropriate by the President for purposes of national defense. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o zabezpieczeniu dostaw leków i sprzętu medycznego w USA\",\n  \"pl_summary\": \"Ustawa ma na celu zapewnienie stałego dostępu do niezbędnych leków i wyrobów medycznych poprzez wzmocnienie krajowej produkcji. Dzięki temu obywatele mają mieć pewność, że kluczowe środki medyczne nie zabraknie w sytuacjach kryzysowych.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie strategii ochrony łańcuchów dostaw leków i sprzętu medycznego.\",\n    \"Wsparcie finansowe dla amerykańskich firm produkujących kluczowe komponenty medyczne.\",\n    \"Zmniejszenie zależności od zagranicznych dostawców w obszarze ochrony zdrowia.\",\n    \"Regularne raporty dla Kongresu o stanie bezpieczeństwa medycznego kraju.\"\n  ],\n  \"eng_ai_title\": \"Protecting America's Medical Supply Chains Act of 2026\",\n  \"eng_summary\": \"This act aims to ensure a steady supply of essential medicines and medical devices by strengthening domestic production. It helps guarantee that citizens have access to life-saving treatments even during global supply disruptions.\",\n  \"eng_key_points\": [\n    \"Creates a national strategy to secure medicines and medical equipment.\",\n    \"Provides funding for US companies to improve supply chain security.\",\n    \"Reduces reliance on foreign governments for critical medical components.\",\n    \"Requires annual updates on the availability of essential medical supplies.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Sicherung der medizinischen Lieferketten in den USA\",\n  \"de_summary\": \"Dieses Gesetz soll die Versorgung mit wichtigen Medikamenten und Medizinprodukten durch die Stärkung der heimischen Produktion sicherstellen. Bürger sollen so auch in Krisenzeiten zuverlässigen Zugang zu notwendigen medizinischen Mitteln haben.\",\n  \"de_key_points\": [\n    \"Entwicklung einer Strategie zur Sicherung von Medikamenten- und Gerätelieferungen.\",\n    \"Finanzielle Unterstützung für US-Unternehmen bei der Sicherung von Lieferketten.\",\n    \"Verringerung der Abhängigkeit von ausländischen Lieferanten im Gesundheitsbereich.\",\n    \"Jährliche Berichte über den Stand der medizinischen Versorgungssicherheit.\"\n  ],\n  \"fr_ai_title\": \"Loi sur la protection des chaînes d'approvisionnement médical aux États-Unis\",\n  \"fr_summary\": \"Cette loi vise à garantir un approvisionnement stable en médicaments et dispositifs médicaux essentiels en renforçant la production nationale. Elle assure aux citoyens l'accès aux soins nécessaires, même en cas de crise internationale.\",\n  \"fr_key_points\": [\n    \"Création d'une stratégie nationale pour sécuriser les médicaments et le matériel médical.\",\n    \"Soutien financier aux entreprises américaines pour renforcer leurs chaînes de production.\",\n    \"Réduction de la dépendance envers les gouvernements étrangers pour les composants médicaux critiques.\",\n    \"Rapports annuels sur l'état de la sécurité des approvisionnements médicaux.\"\n  ],\n  \"es_ai_title\": \"Ley de Protección de las Cadenas de Suministro Médico de 2026\",\n  \"es_summary\": \"Esta ley busca asegurar el suministro constante de medicamentos y equipos médicos esenciales mediante el fortalecimiento de la producción nacional. Su objetivo es que los ciudadanos no sufran escasez de tratamientos vitales en momentos de crisis.\",\n  \"es_key_points\": [\n    \"Creación de una estrategia para proteger el suministro de medicinas y equipos.\",\n    \"Apoyo financiero a empresas estadounidenses para asegurar la producción.\",\n    \"Reducción de la dependencia de proveedores extranjeros en el sector salud.\",\n    \"Informes anuales sobre la seguridad y disponibilidad de suministros médicos.\"\n  ],\n  \"it_ai_title\": \"Legge per la protezione delle catene di approvvigionamento medico\",\n  \"it_summary\": \"Questa legge mira a garantire una fornitura costante di farmaci e dispositivi medici essenziali potenziando la produzione interna. L'obiettivo è assicurare ai cittadini l'accesso alle cure necessarie anche durante crisi globali.\",\n  \"it_key_points\": [\n    \"Definizione di una strategia per mettere in sicurezza farmaci e attrezzature mediche.\",\n    \"Sostegno economico alle imprese americane per rafforzare le catene produttive.\",\n    \"Riduzione della dipendenza da governi stranieri per componenti medici critici.\",\n    \"Relazioni annuali sullo stato della sicurezza degli approvvigionamenti sanitari.\"\n  ],\n  \"nl_ai_title\": \"Wet ter bescherming van de medische toeleveringsketens in de VS\",\n  \"nl_summary\": \"Deze wet is bedoeld om de levering van essentiële medicijnen en medische hulpmiddelen te waarborgen door de binnenlandse productie te versterken. Hierdoor krijgen burgers meer zekerheid over de beschikbaarheid van zorgmiddelen in crisistijd.\",\n  \"nl_key_points\": [\n    \"Ontwikkeling van een strategie om de aanvoer van medicijnen en apparatuur te beveiligen.\",\n    \"Financiële steun voor Amerikaanse bedrijven om toeleveringsketens te versterken.\",\n    \"Vermindering van de afhankelijkheid van buitenlandse overheden voor medische producten.\",\n    \"Jaarlijkse rapportages over de status van de medische bevoorradingszekerheid.\"\n  ],\n  \"pt_ai_title\": \"Lei de Proteção das Cadeias de Abastecimento Médico de 2026\",\n  \"pt_summary\": \"Esta lei visa garantir o fornecimento constante de medicamentos e dispositivos médicos essenciais através do reforço da produção nacional. O objetivo é assegurar que os cidadãos tenham acesso a tratamentos vitais mesmo em situações de crise.\",\n  \"pt_key_points\": [\n    \"Criação de uma estratégia para proteger o abastecimento de medicamentos e equipamentos.\",\n    \"Apoio financeiro a empresas americanas para reforçar a segurança da produção.\",\n    \"Redução da dependência de governos estrangeiros para componentes médicos críticos.\",\n    \"Relatórios anuais sobre o estado da segurança dos suprimentos médicos.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Security\",\n    \"Economy\"\n  ]\n}"
    },
    {
      "timestamp": "2026-04-17T11:25:11.745Z",
      "source_url": "https://www.congress.gov/119/bills/hr7777/BILLS-119hr7777ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7777 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7777 To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services _______________________________________________________________________ A BILL To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting America's Medical Supply Chains Act of 2026''. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) Statement of Policy.--Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended-- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: ``(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;''. (b) Strengthening Domestic Capability.--Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended-- (1) in subsection (a), by inserting ``(including medical materials)'' after ``materials''; and (2) in subsection (b)(1), by inserting ``(including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense)'' after ``essential materials''. (c) Strategy on Securing Supply Chains for Medical Materials.-- Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following: ``SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS. ``(a) In General.--Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following: ``(1) A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act. ``(2) An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities. ``(3) Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense. ``(4) A discussion of-- ``(A) any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs; ``(B) a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and ``(C) efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies. ``(b) Progress Report.--Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex. ``(c) Appropriate Members of Congress.--In this section, the term `appropriate Members of Congress' means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.''. SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY. (a) In General.--Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following: ``(h) Investment in Supply Chain Security.-- ``(1) In general.--In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States. ``(2) Eligible entity.--An eligible entity described in this paragraph is an entity that-- ``(A) is organized under the laws of the United States or any jurisdiction within the United States; and ``(B) produces-- ``(i) one or more critical components; ``(ii) critical technology; or ``(iii) one or more products or raw materials for the security of supply chains or supply chain activities. ``(3) Definitions.--In this subsection, the terms `supply chain' and `supply chain activities' have the meanings given those terms by the President by regulation.''. (b) Regulations.-- (1) In general.--Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms ``supply chain'' and ``supply chain activities'' for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a). (2) Scope of definitions.--The definitions required by paragraph (1)-- (A) shall encompass-- (i) the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or (ii) critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and (B) may include variations as determined necessary and appropriate by the President for purposes of national defense. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Protecting America's Medical Supply Chains Act of 2026\nSummary: This act aims to ensure a steady supply of essential medicines and medical devices by strengthening domestic production. It helps guarantee that citizens have access to life-saving treatments even during global supply disruptions.\nKey Points: Creates a national strategy to secure medicines and medical equipment., Provides funding for US companies to improve supply chain security., Reduces reliance on foreign governments for critical medical components., Requires annual updates on the availability of essential medical supplies.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-04-17T11:14:32.586Z",
      "source_url": "https://www.congress.gov/119/bills/hr7777/BILLS-119hr7777ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7777 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7777 To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 3, 2026 Ms. Salazar introduced the following bill; which was referred to the Committee on Financial Services _______________________________________________________________________ A BILL To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting America's Medical Supply Chains Act of 2026''. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) Statement of Policy.--Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended-- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: ``(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;''. (b) Strengthening Domestic Capability.--Section 107 of the Defense Production Act of 1950 (50 U.S.C. 4517) is amended-- (1) in subsection (a), by inserting ``(including medical materials)'' after ``materials''; and (2) in subsection (b)(1), by inserting ``(including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease that are essential to national defense)'' after ``essential materials''. (c) Strategy on Securing Supply Chains for Medical Materials.-- Title I of the Defense Production Act of 1950 (50 U.S.C. 4511 et seq.) is amended by adding at the end the following: ``SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS. ``(a) In General.--Not later than 180 days after the date of the enactment of this section, the President, in consultation with the Secretary of Health and Human Services, the Secretary of Commerce, the Secretary of Homeland Security, and the Secretary of Defense, shall transmit a strategy to the appropriate Members of Congress that includes the following: ``(1) A detailed plan to use the authorities under this title and title III, or any other provision of law, to ensure the supply of medical materials (including drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 351 of the Public Health Service Act (42 U.S.C. 262)) to diagnose, cure, mitigate, treat, or prevent disease) essential to national defense, to the extent necessary for the purposes of this Act. ``(2) An analysis of vulnerabilities to existing supply chains for such medical materials, and recommendations to address the vulnerabilities. ``(3) Measures to be undertaken by the President to diversify such supply chains, as appropriate and as required for national defense. ``(4) A discussion of-- ``(A) any significant effects resulting from the plan and measures described in this subsection on the production, cost, or distribution of biological products or any other devices or drugs; ``(B) a timeline to ensure that essential components of the supply chain for medical materials are not under the exclusive control of a foreign government in a manner that the President determines could threaten the national defense of the United States; and ``(C) efforts to mitigate any risks resulting from the plan and measures described in this subsection to United States competitiveness, scientific leadership, and innovative capacity, including efforts to cooperate and proactively engage with United States allies. ``(b) Progress Report.--Following submission of the strategy under subsection (a), the President shall submit to the appropriate Members of Congress an annual progress report until September 30, 2029, evaluating the implementation of the strategy, and may include updates to the strategy as appropriate. The strategy and progress reports shall be submitted in unclassified form but may contain a classified annex. ``(c) Appropriate Members of Congress.--In this section, the term `appropriate Members of Congress' means the Speaker, majority leader, and minority leader of the House of Representatives, the majority leader and minority leader of the Senate, the Chairman and Ranking Member of the Committee on Financial Services of the House of Representatives, and the Chairman and Ranking Member of the Committee on Banking, Housing, and Urban Affairs of the Senate.''. SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY. (a) In General.--Section 303 of the Defense Production Act of 1950 (50 U.S.C. 4533) is amended by adding at the end the following: ``(h) Investment in Supply Chain Security.-- ``(1) In general.--In addition to other authorities in this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States. ``(2) Eligible entity.--An eligible entity described in this paragraph is an entity that-- ``(A) is organized under the laws of the United States or any jurisdiction within the United States; and ``(B) produces-- ``(i) one or more critical components; ``(ii) critical technology; or ``(iii) one or more products or raw materials for the security of supply chains or supply chain activities. ``(3) Definitions.--In this subsection, the terms `supply chain' and `supply chain activities' have the meanings given those terms by the President by regulation.''. (b) Regulations.-- (1) In general.--Not later than 90 days after the date of the enactment of this Act, the President shall prescribe regulations setting forth definitions for the terms ``supply chain'' and ``supply chain activities'' for the purposes of section 303(h) of the Defense Production Act of 1950 (50 U.S.C. 4533(h)), as added by subsection (a). (2) Scope of definitions.--The definitions required by paragraph (1)-- (A) shall encompass-- (i) the organizations, people, activities, information, and resources involved in the delivery and operation of a product or service used by the Government; or (ii) critical infrastructure as defined in Presidential Policy Directive 21 (February 12, 2013; relating to critical infrastructure security and resilience); and (B) may include variations as determined necessary and appropriate by the President for purposes of national defense. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o zabezpieczeniu dostaw leków i sprzętu medycznego w USA\",\n  \"pl_summary\": \"Ustawa ma na celu zapewnienie stałego dostępu do niezbędnych leków i wyrobów medycznych poprzez wzmocnienie krajowej produkcji. Dzięki temu obywatele mają mieć pewność, że kluczowe środki medyczne nie zabraknie w sytuacjach kryzysowych.\",\n  \"pl_key_points\": [\n    \"Wprowadzenie strategii ochrony łańcuchów dostaw leków i sprzętu medycznego.\",\n    \"Wsparcie finansowe dla amerykańskich firm produkujących kluczowe komponenty medyczne.\",\n    \"Zmniejszenie zależności od zagranicznych dostawców w obszarze ochrony zdrowia.\",\n    \"Regularne raporty dla Kongresu o stanie bezpieczeństwa medycznego kraju.\"\n  ],\n  \"eng_ai_title\": \"Protecting America's Medical Supply Chains Act of 2026\",\n  \"eng_summary\": \"This act aims to ensure a steady supply of essential medicines and medical devices by strengthening domestic production. It helps guarantee that citizens have access to life-saving treatments even during global supply disruptions.\",\n  \"eng_key_points\": [\n    \"Creates a national strategy to secure medicines and medical equipment.\",\n    \"Provides funding for US companies to improve supply chain security.\",\n    \"Reduces reliance on foreign governments for critical medical components.\",\n    \"Requires annual updates on the availability of essential medical supplies.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Sicherung der medizinischen Lieferketten in den USA\",\n  \"de_summary\": \"Dieses Gesetz soll die Versorgung mit wichtigen Medikamenten und Medizinprodukten durch die Stärkung der heimischen Produktion sicherstellen. Bürger sollen so auch in Krisenzeiten zuverlässigen Zugang zu notwendigen medizinischen Mitteln haben.\",\n  \"de_key_points\": [\n    \"Entwicklung einer Strategie zur Sicherung von Medikamenten- und Gerätelieferungen.\",\n    \"Finanzielle Unterstützung für US-Unternehmen bei der Sicherung von Lieferketten.\",\n    \"Verringerung der Abhängigkeit von ausländischen Lieferanten im Gesundheitsbereich.\",\n    \"Jährliche Berichte über den Stand der medizinischen Versorgungssicherheit.\"\n  ],\n  \"fr_ai_title\": \"Loi sur la protection des chaînes d'approvisionnement médical aux États-Unis\",\n  \"fr_summary\": \"Cette loi vise à garantir un approvisionnement stable en médicaments et dispositifs médicaux essentiels en renforçant la production nationale. Elle assure aux citoyens l'accès aux soins nécessaires, même en cas de crise internationale.\",\n  \"fr_key_points\": [\n    \"Création d'une stratégie nationale pour sécuriser les médicaments et le matériel médical.\",\n    \"Soutien financier aux entreprises américaines pour renforcer leurs chaînes de production.\",\n    \"Réduction de la dépendance envers les gouvernements étrangers pour les composants médicaux critiques.\",\n    \"Rapports annuels sur l'état de la sécurité des approvisionnements médicaux.\"\n  ],\n  \"es_ai_title\": \"Ley de Protección de las Cadenas de Suministro Médico de 2026\",\n  \"es_summary\": \"Esta ley busca asegurar el suministro constante de medicamentos y equipos médicos esenciales mediante el fortalecimiento de la producción nacional. Su objetivo es que los ciudadanos no sufran escasez de tratamientos vitales en momentos de crisis.\",\n  \"es_key_points\": [\n    \"Creación de una estrategia para proteger el suministro de medicinas y equipos.\",\n    \"Apoyo financiero a empresas estadounidenses para asegurar la producción.\",\n    \"Reducción de la dependencia de proveedores extranjeros en el sector salud.\",\n    \"Informes anuales sobre la seguridad y disponibilidad de suministros médicos.\"\n  ],\n  \"it_ai_title\": \"Legge per la protezione delle catene di approvvigionamento medico\",\n  \"it_summary\": \"Questa legge mira a garantire una fornitura costante di farmaci e dispositivi medici essenziali potenziando la produzione interna. L'obiettivo è assicurare ai cittadini l'accesso alle cure necessarie anche durante crisi globali.\",\n  \"it_key_points\": [\n    \"Definizione di una strategia per mettere in sicurezza farmaci e attrezzature mediche.\",\n    \"Sostegno economico alle imprese americane per rafforzare le catene produttive.\",\n    \"Riduzione della dipendenza da governi stranieri per componenti medici critici.\",\n    \"Relazioni annuali sullo stato della sicurezza degli approvvigionamenti sanitari.\"\n  ],\n  \"nl_ai_title\": \"Wet ter bescherming van de medische toeleveringsketens in de VS\",\n  \"nl_summary\": \"Deze wet is bedoeld om de levering van essentiële medicijnen en medische hulpmiddelen te waarborgen door de binnenlandse productie te versterken. Hierdoor krijgen burgers meer zekerheid over de beschikbaarheid van zorgmiddelen in crisistijd.\",\n  \"nl_key_points\": [\n    \"Ontwikkeling van een strategie om de aanvoer van medicijnen en apparatuur te beveiligen.\",\n    \"Financiële steun voor Amerikaanse bedrijven om toeleveringsketens te versterken.\",\n    \"Vermindering van de afhankelijkheid van buitenlandse overheden voor medische producten.\",\n    \"Jaarlijkse rapportages over de status van de medische bevoorradingszekerheid.\"\n  ],\n  \"pt_ai_title\": \"Lei de Proteção das Cadeias de Abastecimento Médico de 2026\",\n  \"pt_summary\": \"Esta lei visa garantir o fornecimento constante de medicamentos e dispositivos médicos essenciais através do reforço da produção nacional. O objetivo é assegurar que os cidadãos tenham acesso a tratamentos vitais mesmo em situações de crise.\",\n  \"pt_key_points\": [\n    \"Criação de uma estratégia para proteger o abastecimento de medicamentos e equipamentos.\",\n    \"Apoio financeiro a empresas americanas para reforçar a segurança da produção.\",\n    \"Redução da dependência de governos estrangeiros para componentes médicos críticos.\",\n    \"Relatórios anuais sobre o estado da segurança dos suprimentos médicos.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Security\",\n    \"Economy\"\n  ]\n}"
    }
  ]
}